3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Colonic Neoplasms
2
Neuroendocrine Tumors
1
Colorectal Neoplasms
1
Cholecystolithiasis
1
Interventions
lutetium Lu 177 dotatate
2
Lutetium-177
2
Liquid Biopsy
2
pentetreotide
1
fluorodopa F 18
1
copper dotatate CU-64
1
Yttrium-90
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Single Photon Emission Computed Tomography Computed Tomography
1
Resveratrol
1
Respiratory Therapy
1
Referral and Consultation
1
Quality of Life
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Palliative Care
1
Nutrition Assessment
1
Needles
1
Magnetic Resonance Spectroscopy
1
Endoscopic Mucosal Resection
1
Diet Therapy
1
Data Collection
1
Cryosurgery
1
Control Groups
1
Colectomy
1
Betaine
1
90Y-octreotide, DOTA-Tyr(3)-
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neuroendocrine Tumors
×
Colectomy
×
Clear all
NCT04735198
2025-05-20
TNE-IDC-COLE
Hospital Universitari de Bellvitge
Phase NA
Recruiting
100 enrolled